Seedlabs

Human-to-Mouse Variant Conservation Pre-Screen

A screening service that tells scientists if a human genetic change will actually work in a mouse model.

A pre-flight service for genetically engineered mouse projects that scores a human regulatory variant in both the human and the native mouse sequence context, telling model-generation teams whether a knock-in mouse will reproduce the variant's effect before they pay to build it.

Biochemistry, Genetics and Molecular BiologyGenomics and Chromatin Dynamics
Microbial Symbiosis and ResistancePreclinical drug development — custom animal model generation and target validation

Concept

A go/no-go triage service for custom mouse model projects. When a sponsor wants to engineer a human regulatory variant (e.g., a GWAS hit or a suspected pathogenic non-coding variant) into a mouse to study its effects, the service first runs the variant through a sequence model in both the human genomic context and the corresponding mouse locus, and reports whether the predicted regulatory consequences — expression change, splicing disruption, accessibility change — are conserved in the mouse sequence. Variants with conserved effects proceed to standard point-variant knock-in; non-conserved ones are flagged for alternative designs (e.g., humanized-locus knock-in) or dropped. The single wedge: stop paying six-figure sums and months of vivarium time to build mouse models that were never going to show the phenotype.

Why now

AlphaGenome [0] was trained on both the human genome (5,930 tracks) and the mouse genome (1,128 tracks), so the same variant-effect machinery can be run on mouse sequence — a capability most variant-effect models, trained on a single species, lack. Its variant effect predictions matched or exceeded the strongest external models in 25 of 26 evaluations, so the underlying scores are reliable enough to base a go/no-go decision on, and the authors provide tools for making variant effect predictions directly from sequence, which is exactly the interface a pre-screen service needs. The economics are compelling: custom model generation typically costs six figures and takes months, and a sequence-based pre-screen that flags non-conserved regulatory effects before engineering starts directly cuts wasted projects and misinterpreted preclinical results.

Written by GLM · 8 Oct 2026

AI assessment

Backed by 1 paper94

A high-value, focused B2B service that leverages AlphaGenome's cross-species training to prevent costly failures in custom mouse model generation.

Evidence strength
5/5
The full text explicitly confirms AlphaGenome was trained on both human and mouse genomes and outperforms SOTA models in variant effect prediction across 25 of 26 benchmarks.
Market pull
5/5
The target customers (CROs like Charles River and genOway) manage high-cost, high-risk projects where a 'no-go' signal saves six-figure sums and months of labor.
Novelty & moat
4/5
While other ideas in the catalog focus on human-only annotation or VUS triage, this specifically targets the cross-species conservation gap in preclinical modeling.
Feasibility
4/5
The authors provide the tools for direct sequence-based prediction, meaning the MVP is essentially a wrapper around the AlphaGenome model and a comparative analysis pipeline.
Wedge clarity
5/5
The wedge is extremely sharp: a binary go/no-go pre-screen for a specific, expensive step in the drug development pipeline.
Simplicity / focus
5/5
The idea avoids 'platform' creep, focusing on a single, clear utility: scoring variant conservation between two species.

Scored by Gemma 4 · 8 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • genOwaycompany

    A custom genetically engineered mouse model provider; offering a conservation pre-screen as part of its project scoping reduces failed builds and rework while differentiating its CRISPR knock-in service.

  • The Jackson Laboratoryorganization

    Provides mouse models and model-generation services to thousands of research programs; advising customers which variants will model faithfully improves project outcomes and its own service reputation.

  • Taconic Biosciencescompany

    Custom model generation is a core business line; a pre-flight conservation check lets it steer clients toward designs likely to yield usable models, avoiding costly failed projects.

  • Charles River Laboratoriescompany

    Its preclinical and model-services clients routinely need variant knock-ins; triaging which variants are worth modeling before vivarium work starts protects study budgets and timelines.

Research it builds on

  1. Advancing regulatory variant effect prediction with AlphaGenome
    Natasha S. Latysheva, Natasha S. Latysheva, Jun Cheng et al. · 2026 · 242 citations
    All ideas from this paper →
Leave feedback
feasibility